James Anderson - Procyon Director
| PCYN Stock | USD 0.22 0.02 10.00% |
Director
Mr. James B. Anderson is Chief Financial Officer, Director of Procyon Corporation and Vice President Operations of Amerx Health Care Corporationration, subsidiary of Procyon Corp since 2012.
| Age | 53 |
| Tenure | 12 years |
| Phone | 727 447 2998 |
| Web | https://procyoncorp.com |
James Anderson Latest Insider Activity
Tracking and analyzing the buying and selling activities of James Anderson against Procyon pink sheet is an integral part of due diligence when investing in Procyon. James Anderson insider activity provides valuable insight into whether Procyon is net buyers or sellers over its current business cycle. Note, Procyon insiders must abide by specific rules, including filing SEC forms every time they buy or sell Procyon'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
James Anderson 2 days ago Disposition of 768 shares by James Anderson of First Financial at 22.16 subject to Rule 16b-3 | ||
James Anderson over a month ago Disposition of 3725 shares by James Anderson of First Financial at 22.16 subject to Rule 16b-3 | ||
James Anderson over two months ago Disposition of 925 shares by James Anderson of First Financial at 21.62 subject to Rule 16b-3 | ||
James Anderson over two months ago Disposition of 925 shares by James Anderson of First Financial at 21.62 subject to Rule 16b-3 |
Procyon Management Efficiency
The company has return on total asset (ROA) of (0.0501) % which means that it has lost $0.0501 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0934) %, meaning that it created substantial loss on money invested by shareholders. Procyon's management efficiency ratios could be used to measure how well Procyon manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 9 records | DIRECTOR Age | ||
| Murray Garnick | Cronos Group | 58 | |
| Alan Friedman | Cronos Group | 45 | |
| Bronwen Evans | Cronos Group | 48 | |
| Michael Krestell | Cronos Group | N/A | |
| James Rudyk | Cronos Group | 51 | |
| Bruce Gates | Cronos Group | 56 | |
| Kevin Crosthwaite | Cronos Group | 42 | |
| Ryan Roebuck | Cronos Group | 31 | |
| Jason Adler | Cronos Group | 46 | |
Management Performance
| Return On Equity | -0.0934 | |||
| Return On Asset | -0.0501 |
Procyon Leadership Team
Elected by the shareholders, the Procyon's board of directors comprises two types of representatives: Procyon inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procyon. The board's role is to monitor Procyon's management team and ensure that shareholders' interests are well served. Procyon's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procyon's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Regina Anderson, Chairman and CEO | ||
| Michael Foley, Independent Director | ||
| James Anderson, CFO, Director and VP of Operations - Amerx Health Care Corporate | ||
| Justice Anderson, Pres CEO | ||
| Paul Kudelko, Director | ||
| Fred Suggs, Independent Director | ||
| Joseph Treshler, Independent Director | ||
| George Borak, VP of Sales - Amerx Health Care Corp |
Procyon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Procyon a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0934 | |||
| Return On Asset | -0.0501 | |||
| Profit Margin | (0.05) % | |||
| Operating Margin | (0.07) % | |||
| Current Valuation | 1.82 M | |||
| Shares Outstanding | 8.09 M | |||
| Shares Owned By Insiders | 65.00 % | |||
| Price To Earning | 8.00 X | |||
| Price To Book | 0.77 X | |||
| Price To Sales | 0.40 X |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Procyon using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Procyon. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Procyon Pink Sheet analysis
When running Procyon's price analysis, check to measure Procyon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procyon is operating at the current time. Most of Procyon's value examination focuses on studying past and present price action to predict the probability of Procyon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procyon's price. Additionally, you may evaluate how the addition of Procyon to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |